SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.

Rita A BusuttilJoshy GeorgeColin M HouseStephen LadeCatherine MitchellNatasha S Di CostanzoSharon PattisonYu-Kuan HuangPatrick TanJae-Ho CheongSun Young RhaAlex Boussioutas

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2020)

This simple ELISA-based assay can help predict recurrence of disease after curative gastric cancer surgery irrespective of adjuvant therapy. The results require further evaluation in a prospective trial but would help in the rational prescription of cancer therapies and surveillance to prevent under or over treatment of patients after curative resection.

Keyphrases

free survival
papillary thyroid
minimally invasive
rectal cancer
prognostic factors
coronary artery bypass
public health
clinical trial
study protocol
squamous cell
high throughput
phase iii
cell migration
phase ii
squamous cell carcinoma
acute coronary syndrome
open label